TenderlineUK
Procurement Intelligence
Official OCDS

Retender radar: UK public contracts ending soon

Public contracts ending ahead, with the buyer, the incumbent and the value. Where a notice gives only a duration, the end is estimated and labelled. An end date can signal a new tender; it does not promise one.

in Retenders

Syntax:"exact phrase"cleaning OR cateringsoftware -consultancy(cleaning OR catering) AND hospitalgovern*admin+defence

Contracts ending in the all future end dates

Showing 59,276–59,300

SortEnding soonestLargest published valueLargest annual run-rate, exc. VAT

60,647 contracts

  1. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Bowmed Ibisqus Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £283kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  2. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Morningside Pharmaceuticals Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £266kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  3. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Amarox Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £222kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  4. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Thornton and Ross Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £217kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  5. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Zentiva Pharma UK Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £213kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  6. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: hameln pharma ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £210kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  7. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Ferring Pharmaceuticals Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £207kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  8. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: NOVARTIS PHARMACEUTICALS UK LIMITED · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £131kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  9. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: medac Pharma LLP · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £120kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  10. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Sun Pharma UK Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £106kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  11. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: ACCORD-UK LTD · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £87kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  12. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Desitin Pharma Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £86kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  13. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: MACARTHYS LABORATORIES LTD T/A MARTINDALE PHARMA · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £83kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  14. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: B. Braun Medical Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £83kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  15. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Fresenius Kabi Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £54kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  16. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Rosemont Pharmaceuticals Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £46kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  17. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Typharm Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £41kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  18. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Bayer plc Radiology · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £34kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  19. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Kent Pharmaceuticals Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £30kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  20. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Wockhardt UK Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £26kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  21. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Chiesi Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £26kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  22. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Neuraxpharm UK Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £24kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  23. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Janssen-Cilag Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £21kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  24. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Recordati Pharmaceuticals Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £18kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0
  25. Estimated end · in 2,755 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 14

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Napp Pharmaceuticals Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £14kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 11 May 2034 · start not published
    Reference
    ocds-h6vhtk-0437e0

When contracts end
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

An end date does not confirm a new procurement.

38,151 contracts and agreements end within 24 months, 60,647 in total · £224bn published GBP values end in the all future end dates, exc. VAT; framework and DPS values, concession values and other ceiling-like amounts are excluded, so this is not a spend forecast.

  1. Next 3 months5,748
  2. 3–6 months8,048
  3. 6–12 months10,124
  4. 12–24 months14,231

By sector, all future end dates
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

An end date does not confirm a new procurement.

Contracts ending in the chosen window, by category.

CPV division of the procedure; a contract with several divisions counts in each.

How to read the radar
  • End date is the contract period end the buyer published on the notice (or on the lot). Where the notice gives only a duration, the end is estimated as the signature date (or, without one, the publication date) plus that duration, and the row says so. Contracts with neither are not on the radar; neither are contracts the buyer cancelled or terminated early.
  • List or panel totals. When one total is repeated on every provider of an approved list or panel, it is shown on the row but never added to the GBP totals or used for a run-rate.
  • Extension option means the notice publishes a renewal or option clause; the buyer may extend. Hiding these rows shows contracts without a published option, but does not establish that the buyer will procure them again.
  • Incumbent is the supplier named on the award behind the contract. A panel (several suppliers on one award) is shown as a panel; no single incumbent is invented.
  • Annual run-rate = published GBP value ÷ published term for a single supplier and a term of six months or more. Values linked to a framework or DPS have no run-rate until we can tell whether they are a ceiling or a contract. The annual sort ranks comparable values excluding VAT first; gross-only values remain visible on their rows. This is not actual annual spend.
  • Counts are exact for the time-horizon and sector filters. A parent framework or DPS counts once; call-offs published by other buyers count separately. Where the parent cannot be identified, agreements stay separate and are marked as linked to a framework or DPS; check the source notice before treating their date or value as a single contract fact. With other filters, a result above 1,000 rows shows as “1,000+”.
  • Source. Official UK procurement notices, reused under the Open Government Licence v3.0; the radar is rebuilt nightly. How we count: methodology.